Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/22/2012US20120070465 Pharmaceutical composition for modified release
03/22/2012US20120070453 Methods for Preparing and Delivering Adjuvant Compositions
03/22/2012US20120070385 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
03/22/2012US20120070384 Topical antifungal composition
03/22/2012US20120070380 Ingestible salt grabber
03/22/2012US20120070376 Yeast cell wall particles for receptor-targeted nanoparticle delivery
03/22/2012US20120068219 Microencapsulated particles and process for manufacturing same
03/22/2012US20120067923 Method of producing foamed cleansert with suspended particles therein and a dispenser therefore
03/22/2012US20120067361 Plant fiber product and method for its manufacture
03/22/2012CA2812189A1 Micro devices for biomedical applications and uses of the same
03/22/2012CA2811526A1 Non-aqueous oily injectable formulation exhibiting preservative efficacy
03/22/2012CA2811494A1 Octreotide-modified nanomedicine for cancer treatment or cancer palliative care
03/22/2012CA2811202A1 Aqueous drug delivery system comprising off-flavor masking agent
03/22/2012CA2810734A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012CA2810731A1 Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral ph
03/22/2012CA2810598A1 Pharmaceutical composition
03/22/2012CA2810243A1 Formulations of guanylate cyclase c agonists and methods of use
03/21/2012EP2431405A1 Fine particles of crystalline polyol and method of preparing same
03/21/2012EP2431089A1 Metal oxide coating of water insoluble ingredients
03/21/2012EP2431088A1 Metal oxide coating of water insoluble ingredients
03/21/2012EP2431056A1 Pharmaceutical compound containing electrochemically active salt solution
03/21/2012EP2431055A1 Conjugates of membrane translocating agents and pharmaceutically active agents
03/21/2012EP2431049A2 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/21/2012EP2431038A1 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles
03/21/2012EP2431036A1 Macrocyclic lactone compounds and methods for their use
03/21/2012EP2431034A1 Adhesive patch-containing package bag and method for storing adhesive patch
03/21/2012EP2431030A1 Treatment of fungal infections
03/21/2012EP2431028A2 Fast-dissolving oral film for effectively concealing unpleasant tastes
03/21/2012EP2431027A1 Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
03/21/2012EP2431026A1 Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
03/21/2012EP2431025A1 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
03/21/2012EP2431024A1 Method for stabilising blood plasma contents in a lyophilisate
03/21/2012EP2431023A1 Flexible liposome of resveratrol and preparation method thereof
03/21/2012EP2430923A1 Compositions and methods for liver growth and liver protection
03/21/2012EP2429659A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
03/21/2012EP2429658A2 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
03/21/2012EP2429624A1 Expandable devices and methods therefor
03/21/2012EP2429569A2 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
03/21/2012EP2429559A1 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
03/21/2012EP2429528A2 Orodispersible tablet containing a vardenafil salt
03/21/2012EP2429521A2 Sublingual dexmedetomidine compositions and methods of use thereof
03/21/2012EP2429510A1 Oil-in-water emulsion of mometasone and propylene glycol
03/21/2012EP2429507A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma
03/21/2012EP2429506A1 Coated pharmaceutical capsule dosage form
03/21/2012EP2429505A1 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
03/21/2012EP2429504A1 Film coatings containing fine particle size detackifiers and substrates coated therewith
03/21/2012EP2429503A1 Pharmaceutical system for trans-membrane delivery
03/21/2012EP2429502A1 Method and composition to improve absorption of therapeutic agents
03/21/2012EP2429501A1 Burst drug release compositions
03/21/2012EP2429500A1 Method to stabilize a dietary supplement comprising glucosamine
03/21/2012EP2429499A2 Method for impregnation with supercrtitical co2
03/21/2012EP2429498A2 New oral formulations for tetrapyrrole derivatives
03/21/2012EP2429497A2 Microparticles comprising immunosuppressant
03/21/2012EP2429496A1 Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds
03/21/2012EP2429495A1 Intranasal pharmaceutical compositions with improved pharmacokinetics
03/21/2012EP2429494A2 Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
03/21/2012EP2429493A1 Compositions and methods for drug delivery
03/21/2012EP2429492A2 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
03/21/2012EP2429491A2 Hyaluronic acid (ha) injection vehicle
03/21/2012EP2429490A1 Oil-in-water emulsion of mometasone
03/21/2012EP2429314A1 Granular delivery system
03/21/2012EP2429313A1 Method of preparing a granular delivery system
03/21/2012EP2429308A2 Chlorine dioxide based gum and candy
03/21/2012EP2429297A1 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
03/21/2012EP2323633B1 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
03/21/2012EP2249817B8 Nanoparticle carriers for drug administration and process for producing same
03/21/2012EP2151241B1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
03/21/2012EP2018869B1 Licorice polyphenol preparation
03/21/2012EP2018154B1 Hydrogel suspension and manufacturing process thereof
03/21/2012EP1789139B1 Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl amino -2-pyrimidinyl amino benzonitrile
03/21/2012EP1784169B1 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
03/21/2012EP1771155B1 Method and composition for treating rhinitis
03/21/2012EP1734923B1 Zinc preservative composition and method of use
03/21/2012EP1608339B1 Pharmaceutical co-crystal of celecoxib-nicotinamide
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1478399B1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
03/21/2012EP1441778B1 Laminated patient infusion device
03/21/2012EP0708805B9 Seals for use in an aerosol delivery device
03/21/2012EP0692972B2 Method for delivering beneficial compositions to hair follicles
03/21/2012CN202168960U 含有奥美沙坦酯、氨氯地平和氢氯噻嗪的复方制剂 Compound preparations containing olmesartan medoxomil, amlodipine and hydrochlorothiazide in
03/21/2012CN1917861B Stabilised compositions of factor vii polypeptides
03/21/2012CN1868506B Medicine prepns. used for treating cardiovascular disease, and its prepn. method
03/21/2012CN1809607B Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device
03/21/2012CN1440745B Fluoxetine medicinal preparation
03/21/2012CN102388021A Process for preparing pyrrolidinium salts
03/21/2012CN102387802A Immediate release pharmaceutical compositions comprising oxycodone and naloxone
03/21/2012CN102387795A Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
03/21/2012CN102387792A 固体制剂 Solid preparations
03/21/2012CN102387791A Formulation for stabilizing proteins, which is free of mammalian excipients
03/21/2012CN102387790A Lyophilization cakes of proteasome inhibitors
03/21/2012CN102387789A Delayed release, oral dosage compositions that contain amorphous cddo-me
03/21/2012CN102387788A Bioavailable compositions of amorphous alpha-(n-sulfonamido) acetamide compound
03/21/2012CN102387787A Preparation for external application
03/21/2012CN102387786A Antimycotic pharmaceutical composition
03/21/2012CN102387785A Antimycotic pharmaceutical composition
03/21/2012CN102387784A Lyophilized recombinant vwf formulations
03/21/2012CN102387783A Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
03/21/2012CN102387782A Regulation of bone growth using zeolite in combination with bone graft substitutes
03/21/2012CN102382839A Anti-herpes simplex virus (HSV) active polypeptide of Tibetan Pi scorpion and application thereof
03/21/2012CN102382125A Cefditoren water-soluble composite, preparation method and corresponding pharmaceutical preparation thereof
1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 2991